Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03588936
Brief Title: Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant

First Submitted : July 4, 2018
First Submitted that Met QC Criteria : July 16, 2018
First Posted : July 17, 2018

Last Update Submitted that Met QC Criteria : August 21, 2019
Last Update Posted : August 26, 2019